Foley & Lardner·FDA / LIFE SCIENCES REGULATORY

HHS Announces Limited Enforcement Discretion for Six Compounded Peptides

HHS says it will exercise limited enforcement discretion over 503A pharmacies compounding six peptide bulk drug substances — BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500 — with comments due Nov. 13, 2026.

compounding-pharmaciesenforcement-discretionpeptide-bulk-drug-substanceshhsfda-503arulemaking-comment-period
Read the original firm alert → Sunday, November 1, 2026

Stay ahead

Join the digest.

Each weekday's issue by email, through Substack. Or follow the RSS feed.

Subscribe on SubstackRSS feed